Carcinoma of Urinary Bladder, Superficial Completed Phase 4 Trials for Epirubicin (DB00445)

IndicationStatusPhase
DBCOND0034921 (Carcinoma of Urinary Bladder, Superficial)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02214602Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder CancerPrevention